DBT: Ben Tre Pharmaceutical Joint Stock Company - Summary | Jitta

Ben Tre Pharmaceutical Joint Stock Company

VNM:DBT

Price
₫12,600.00
Loss Chance
54.1%
2.90JITTA SCORE
131.32%Over Jitta Line
Jitta Ranking
501 / 634
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (24)
Recent Business Performance (29)
Financial Strength (54)
Return to Shareholders (14)
Competitive Advantage (34)
Jitta Signs
Debt LevelLow Long Term Debt
Operating MarginInconsistent
Recent Business PerformanceEarning decline 277.83% in the last quarter (yoy)
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
2.90
131.32%
4.25
245.79%
3.86
200.61%
Pharmaceuticals
5.90
81.39%
4.60
119.02%
3.71
> 1,000%
COMPANY DESCRIPTION
Ben Tre Pharmaceutical Joint Stock Company manufactures, distributes, and sells pharmaceutical products in Vietnam and internationally. The company offers drugs in injectable, infusion, pill, and lotion forms. The company provides products covering various therapeutic areas, including central nervous system, respiratory system, endocrinology, obstetrics and gynecology, anti-allergic, cardiovascular, antibiotics, anti-fungal, anti-viral, musculoskeletal, vitamins and minerals, digestive, hepatobiliary and urinary, pain relief, fever reducer, anti-inflammatory, on-site impact, and diabetics, as well as herbal medicines. It offers supplements and medical devices. The company was founded in 1963 and is headquartered in Ben Tre, Vietnam.